Clampdown of inflammation in aging and anticancer therapies by limiting upregulation and activation of GPCR, CXCR4

A sensing protein that is increased in response to DNA damage can be targeted to reduce inflammation and collateral damage during anti-cancer therapy and aging.  

Browse Articles

Nature events Directory

  • This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

    Committee on Publication Ethics